{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:22:39Z","timestamp":1790356959661,"version":"4.1.0"},"reference-count":178,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI28697"],"award-info":[{"award-number":["P30AI28697"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U19AI117941"],"award-info":[{"award-number":["1U19AI117941"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R33AI122390"],"award-info":[{"award-number":["1R33AI122390"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 AI131294"],"award-info":[{"award-number":["P01 AI131294"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21AI122390"],"award-info":[{"award-number":["1R21AI122390"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA239261"],"award-info":[{"award-number":["R01CA239261"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI140775"],"award-info":[{"award-number":["1R01AI140775"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2020.00410","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:52:15Z","timestamp":1597279935000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":56,"title":["Engineering CAR T Cells to Target the HIV Reservoir"],"prefix":"10.3389","volume":"10","author":[{"given":"Wenli","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra A.","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G.","family":"Kitchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nbt.4086","article-title":"IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor","volume":"36","author":"Adachi","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.3389\/fmicb.2019.03060","article-title":"Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs","volume":"10","author":"Ait-Ammar","year":"2019","journal-title":"Front. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"6999","DOI":"10.1128\/JVI.00805-16","article-title":"HIV-1-specific chimeric antigen receptors based on broadly neutralizing antibodies","volume":"90","author":"Ali","year":"2016","journal-title":"J. Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1126\/scitranslmed.aav5685","article-title":"Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model","volume":"11","author":"Anthony-Gonda","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.192.1.63","article-title":"HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function","volume":"192","author":"Appay","year":"2000","journal-title":"J. Exp. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1172\/JCI92684","article-title":"Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency","volume":"127","author":"Archin","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"2012","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nm.4113","article-title":"PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals","volume":"22","author":"Banga","year":"2016","journal-title":"Nat. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV antibody VRC01 on viral rebound after treatment interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41591-018-0186-4","article-title":"Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals","volume":"24","author":"Bar-On","year":"2018","journal-title":"Nat. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.imlet.2018.02.004","article-title":"The role of latency reversal agents in the cure of HIV: a review of current data","volume":"196","author":"Bashiri","year":"2018","journal-title":"Immunol. Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1158\/2326-6066.CIR-19-0293","article-title":"Glypican-3-specific CAR T cells coexpressing IL15 and IL21 have superior expansion and antitumor activity against hepatocellular carcinoma","volume":"8","author":"Batra","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.chom.2016.07.015","article-title":"Single-cell characterization of viral translation-competent reservoirs in HIV-infected individuals","volume":"20","author":"Baxter","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1182\/blood-2004-02-0696","article-title":"Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules","volume":"104","author":"Bonaparte","year":"2004","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nature20583","article-title":"Ad26\/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys","volume":"540","author":"Borducchi","year":"2016","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"39032","DOI":"10.1038\/srep39032","article-title":"In vitro effects of the small-molecule protein kinase C agonists on HIV latency reactivation","volume":"6","author":"Brogdon","year":"2016","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"Bruner","year":"2016","journal-title":"Nat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1002\/eji.200838833","article-title":"Tumor cell recognition by the NK cell activating receptor NKG2D","volume":"38","author":"Bryceson","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1004251","DOI":"10.1371\/journal.ppat.1004251","article-title":"T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection","volume":"10","author":"Buggert","year":"2014","journal-title":"PLoS Pathog."},{"key":"B20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"Bullen","year":"2014","journal-title":"Nat. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1126\/science.7973652","article-title":"Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody","volume":"266","author":"Burton","year":"1994","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trsl.2017.07.002","article-title":"New approaches for the enhancement of chimeric antigen receptors for the treatment of HIV","volume":"187","author":"Carrillo","year":"2017","journal-title":"Transl. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1172\/JCI83092","article-title":"Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition","volume":"126","author":"Cherkassky","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1158\/1078-0432.CCR-11-3050","article-title":"Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice","volume":"18","author":"Chinnasamy","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1517\/14712598.2015.1046430","article-title":"TRUCKs: the fourth generation of CARs","volume":"15","author":"Chmielewski","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/imr.12125","article-title":"Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma","volume":"257","author":"Chmielewski","year":"2014","journal-title":"Immunol. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/9498","article-title":"Effect of interleukin-2 on the pool of latently infected, resting CD4(+) T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy","volume":"5","author":"Chun","year":"1999","journal-title":"Nature Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2174\/157016208786501472","article-title":"The utility of ADCC responses in HIV infection","volume":"6","author":"Chung","year":"2008","journal-title":"Curr. HIV Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/QAI.0b013e31822c62b9","article-title":"Activation of NK cells by ADCC antibodies and HIV disease progression","volume":"58","author":"Chung","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2015.5","article-title":"HIV reservoirs: what, where and how to target them","volume":"14","author":"Churchill","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"30749","DOI":"10.1038\/srep30749","article-title":"The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function","volume":"6","author":"Clutton","year":"2016","journal-title":"Sci. Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3389\/fimmu.2018.01452","article-title":"Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure","volume":"9","author":"Clutton","year":"2018","journal-title":"Front. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/j.celrep.2016.02.022","article-title":"IL-7 induces SAMHD1 phosphorylation in CD4+ T Lymphocytes, improving early steps of HIV-1 life cycle","volume":"14","author":"Coiras","year":"2016","journal-title":"Cell Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/34929","article-title":"HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes","volume":"391","author":"Collins","year":"1998","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1005063","DOI":"10.1371\/journal.ppat.1005063","article-title":"An in-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression","volume":"11","author":"Darcis","year":"2015","journal-title":"PLoS Pathog."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/s41467-019-10366-y","article-title":"Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice","volume":"10","author":"Dash","year":"2019","journal-title":"Nat. Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1006\/mthe.2002.0611","article-title":"A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy","volume":"5","author":"Deeks","year":"2002","journal-title":"Mol. Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2018.01514","article-title":"In vitro exposure to prostratin but not bryostatin-1 improves natural killer cell functions including killing of CD4+ T cells harboring reactivated human immunodeficiency virus","volume":"9","author":"Desimio","year":"2018","journal-title":"Front. Immunol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/srep12442","article-title":"Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-\u03baB-dependent mechanism","author":"D\u00edaz","year":"2015","journal-title":"Sci. Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature13036","article-title":"Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies","volume":"509","author":"Doria-Rose","year":"2014","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.4049\/jimmunol.179.3.1979","article-title":"Programmed death 1 expression on HIV-specific CD4(+) T cells is driven by viral replication and associated with T cell dysfunction","volume":"179","author":"D'Souza","year":"2007","journal-title":"J. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e1004473","DOI":"10.1371\/journal.ppat.1004473","article-title":"Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy","volume":"10","author":"Elliott","year":"2014","journal-title":"PLoS Pathog"},{"key":"B44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1128\/JVI.01748-17","article-title":"ALT-803 transiently reduces simian immunodeficiency virus replication in the absence of antiretroviral treatment","volume":"92","author":"Ellis-Connell","year":"2018","journal-title":"J. Virol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1073\/pnas.90.2.720","article-title":"Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors","volume":"90","author":"Eshhar","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1126\/science.1066371","article-title":"Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR","volume":"294","author":"Feinberg","year":"2001","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/imr.12823","article-title":"T-cell exhaustion in HIV infection","volume":"292","author":"Fenwick","year":"2019","journal-title":"Immunol. Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrc.2016.97","article-title":"Engineered T cells: the promise and challenges of cancer immunotherapy","volume":"16","author":"Fesnak","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nm.4441","article-title":"CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/QAD.0000000000001267","article-title":"Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques","volume":"31","author":"Gama","year":"2017","journal-title":"AIDS"},{"key":"B51","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3389\/fimmu.2016.00356","article-title":"HIV latency-reversing agents have diverse effects on natural killer cell function","volume":"7","author":"Garrido","year":"2016","journal-title":"Front. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jcyt.2017.11.001","article-title":"Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity","volume":"20","author":"Ghanem","year":"2018","journal-title":"Cytotherapy"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/vew020","article-title":"Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy","author":"Gianella","year":"2016","journal-title":"Virus Evol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/15184","article-title":"The great escape - AIDS viruses and immune control","volume":"5","author":"Goulder","year":"1999","journal-title":"Nat. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1742-4690-7-30","article-title":"Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection","volume":"7","author":"Gras","year":"2010","journal-title":"Retrovirology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e1007991","DOI":"10.1371\/journal.ppat.1007991","article-title":"Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations","volume":"15","author":"Grau-Exp\u00f3sito","year":"2019","journal-title":"PLoS Pathog"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/imr.12128","article-title":"Hematopoietic stem cells for cancer immunotherapy","volume":"257","author":"Gschweng","year":"2014","journal-title":"Immunol. Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.omtm.2018.12.009","article-title":"Engineering and design of chimeric antigen receptors","volume":"12","author":"Guedan","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1097\/QAD.0000000000001064","article-title":"Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy","volume":"30","author":"Gutierrez","year":"2016","journal-title":"AIDS"},{"key":"B61","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ymthe.2016.12.023","article-title":"Engineering HIV-resistant, anti-HIV chimeric antigen receptor T cells","volume":"25","author":"Hale","year":"2017","journal-title":"Mol. Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fimmu.2018.00492","article-title":"Simian immunodeficiency virus (SIV)-specific chimeric antigen receptor-T cells engineered to target B cell follicles and suppress SIV replication","volume":"9","author":"Haran","year":"2018","journal-title":"Front. Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.cell.2019.10.002","article-title":"Attacking latent HIV with convertibleCAR-T cells, a highly adaptable killing platform","volume":"179","author":"Herzig","year":"2019","journal-title":"Cell"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/sj.gt.3302023","article-title":"T-cell activation by recombinant immunoreceptors: impact of the intracellular signalling domain on the stability of receptor expression and antigen-specific activation of grafted T cells","volume":"10","author":"Heuser","year":"2003","journal-title":"Gene Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/leu.2010.75","article-title":"Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma\/leukemia effects and safety","volume":"24","author":"Hoyos","year":"2010","journal-title":"Leukemia"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1016\/j.celrep.2017.09.002","article-title":"Augmentation of antitumor immunity by human and mouse CAR T cells secreting IL-18","volume":"20","author":"Hu","year":"2017","journal-title":"Cell Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1089\/hum.2017.234","article-title":"Nucleofection with plasmid DNA for CRISPR\/Cas9-mediated inactivation of programmed cell death protein 1 in CD133-specific CAR T cells","volume":"30","author":"Hu","year":"","journal-title":"Hum. Gene Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00262-018-2281-2","article-title":"CRISPR\/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions","volume":"68","author":"Hu","year":"","journal-title":"Cancer Immunol. Immunother."},{"key":"B69","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"Huang","year":"2012","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-binding-site antibody to HIV that evolved near-pan neutralization breadth","volume":"45","author":"Huang","year":"2016","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1172\/JCI97555","article-title":"Latent HIV reservoirs exhibit inherent resistance to elimination by CD8(+) T cells","volume":"28","author":"Huang","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B72","doi-asserted-by":"publisher","first-page":"E7788","DOI":"10.1073\/pnas.1610544113","article-title":"Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells","volume":"113","author":"Hurton","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1126\/science.1195271","article-title":"The major genetic determinants of HIV-1 control affect HLA class I peptide presentation","volume":"330","year":"2010","journal-title":"Science"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1089\/aid.2014.0199","article-title":"Targeting NF-kappa B signaling with protein kinase C agonists as an emerging strategy for combating HIV latency","volume":"1","author":"Jiang","year":"2015","journal-title":"Aids Res. Human Retrov."},{"key":"B75","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1371\/journal.ppat.1005545","article-title":"A subset of latency-reversing agents expose HIV-infected resting CD4(+) T-cells to recognition by cytotoxic T-lymphocytes","volume":"12","author":"Jones","year":"2016","journal-title":"PLoS Pathogens."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e1004287","DOI":"10.1371\/journal.ppat.1004287","article-title":"Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes","volume":"10","author":"Jones","year":"2014","journal-title":"PLoS Pathog"},{"key":"B77","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1172\/JCI80566","article-title":"HIV-specific CD8(+) T cells and HIV eradication","volume":"126","author":"Jones","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B78","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","first-page":"95r","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbrc.2015.05.026","article-title":"Ectopic expression of anti-HIV-1 shRNAs protects CD8(+) T cells modified with CD4zeta CAR from HIV-1 infection and alleviates impairment of cell proliferation","volume":"463","author":"Kamata","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B81","doi-asserted-by":"publisher","first-page":"22555","DOI":"10.1038\/srep28213","article-title":"Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR\/Cas9 gene editing","volume":"6","author":"Kaminski","year":"2016","journal-title":"Sci. Rep."},{"key":"B82","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.immuni.2016.02.023","article-title":"Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T Cells","volume":"44","author":"Kawalekar","year":"2016","journal-title":"Immunity"},{"key":"B83","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","article-title":"Getting the Kill into Shock and Kill: strategies to eliminate latent HIV","volume":"23","author":"Kim","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e1002649","DOI":"10.1371\/journal.ppat.1002649","article-title":"In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells","volume":"8","author":"Kitchen","year":"2012","journal-title":"PLoS Pathog."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1200\/JCO.2016.71.3024","article-title":"Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels","volume":"35","author":"Kochenderfer","year":"2017","journal-title":"In. J. Clin. Oncol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/COH.0000000000000485","article-title":"Chimeric antigen receptor T-cell approaches to HIV cure","volume":"13","author":"Kuhlmann","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"B88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1128\/JVI.00969-19","article-title":"Differentiation into an effector memory phenotype potentiates HIV-1 latency reversal in CD4(+) T cells","volume":"93","author":"Kulpa","year":"2019","journal-title":"J. Virol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41551-018-0235-9","article-title":"Programming CAR-T cells to kill cancer","volume":"2","author":"Labanieh","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1172\/JCI80142","article-title":"Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations","volume":"125","author":"Laird","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B91","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/icb.2013.111","article-title":"Advances in NKG2D ligand recognition and responses by NK cells","volume":"92","author":"Le Bert","year":"2014","journal-title":"Immunol. Cell. Biol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e1006613","DOI":"10.1371\/journal.ppat.1006613","article-title":"Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor","volume":"13","author":"Leibman","year":"2017","journal-title":"PLoS Pathog."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e1005983","DOI":"10.1371\/journal.ppat.1005983","article-title":"Potent and broad inhibition of HIV-1 by a peptide from the gp41 heptad repeat-2 domain conjugated to the CXCR4 amino terminus","volume":"12","author":"Leslie","year":"2016","journal-title":"PLoS Pathog."},{"key":"B94","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/cid\/cis383","article-title":"Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I\/IIa randomized, placebo-controlled, multicenter study","volume":"55","author":"Levy","year":"2012","journal-title":"Clin. Infectious Diseases"},{"key":"B95","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1126\/scitranslmed.aao4521","article-title":"TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy","volume":"10","author":"Lim","year":"2018","journal-title":"Sci. Trans. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/mt.2015.213","article-title":"CRISPR-mediated activation of latent HIV-1 expression","volume":"24","author":"Limsirichai","year":"2016","journal-title":"Mol. Ther."},{"key":"B97","doi-asserted-by":"publisher","first-page":"9712","DOI":"10.1128\/JVI.00852-16","article-title":"Chimeric antigen receptor T cells guided by the single-chain Fv of a broadly neutralizing antibody specifically and effectively eradicate virus reactivated from latency in CD4+ T lymphocytes isolated from HIV-1-infected individuals receiving suppressive combined antiretroviral therapy","volume":"90","author":"Liu","year":"2016","journal-title":"J. Virol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s13238-017-0415-5","article-title":"Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV","volume":"8","author":"Liu","year":"2017","journal-title":"Protein Cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1172\/jci.insight.122673","article-title":"Dual TLR2 and TLR7 agonists as HIV latency-reversing agents","volume":"3","author":"Macedo","year":"2018","journal-title":"Jci. Insight"},{"key":"B101","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.virol.2006.02.019","article-title":"Interleukin-7 induces HIV replication in primary naive T cells through a nuclear factor of activated T cell (NFAT)-dependent pathway","volume":"350","author":"Managlia","year":"2006","journal-title":"Virology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"E9659","DOI":"10.1073\/pnas.1806695115","article-title":"IL-15 regulates susceptibility of CD4(+) T cells to HIV infection","volume":"115","author":"Manganaro","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B103","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fimmu.2016.00397","article-title":"Targeting the brain reservoirs: toward an HIV Cure","volume":"7","author":"Marban","year":"2016","journal-title":"Front. Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1371\/journal.ppat.1006575","article-title":"In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell kick and kill in strategy for virus eradication","volume":"13","author":"Marsden","year":"2017","journal-title":"PLoS Pathogens"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-020-1946-0","article-title":"Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8(+) cells","volume":"578","author":"McBrien","year":"2020","journal-title":"Nature."},{"key":"B107","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fimmu.2018.00283","article-title":"Chimeric antigen receptor expressing natural killer cells for the immunotherapy of cancer","volume":"9","author":"Mehta","year":"2018","journal-title":"Front. Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","article-title":"Combination therapy with anti-HIV-1 antibodies maintains viral suppression","author":"Mendoza","year":"2018","journal-title":"Nature"},{"key":"B109","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1182\/blood.V96.3.785","article-title":"Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects","volume":"96","author":"Mitsuyasu","year":"2000","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1182\/blood-2017-06-786129","article-title":"Cellular kinetics of CTL019 in relapsed\/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia","volume":"130","author":"Mueller","year":"2017","journal-title":"Blood"},{"key":"B111","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4049\/jimmunol.180.1.350","article-title":"IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses","volume":"180","author":"Mueller","year":"2008","journal-title":"J. Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1073\/pnas.1621418114","article-title":"Dynamics of SIV-specific CXCR5+ CD8 T cells during chronic SIV infection","volume":"114","author":"Mylvaganam","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B113","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1128\/JVI.00222-16","article-title":"A novel toll-like receptor 9 agonist, MGN1703, enhances HIV-1 transcription and NK cell-mediated inhibition of HIV-1-infected autologous CD4(+) T Cells","volume":"90","author":"Offersen","year":"2016","journal-title":"J. Virol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s10875-005-8786-4","article-title":"NKG2D in NK and T cell-mediated immunity","volume":"25","author":"Ogasawara","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1126\/scitranslmed.aaa0984","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma","volume":"9","author":"O'Rourke","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"e1005782","DOI":"10.1371\/journal.ppat.1005782","article-title":"Histone deacetylase inhibitors enhance CD4 T cell susceptibility to NK cell killing but reduce NK cell function","volume":"12","author":"Pace","year":"2016","journal-title":"PLoS Pathog"},{"key":"B117","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4049\/jimmunol.1201108","article-title":"In vivo blockade of the PD-1 receptor suppresses HIV-1 viral loads and improves CD4+ T cell levels in humanized mice","volume":"190","author":"Palmer","year":"2013","journal-title":"J. Immunol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.celrep.2019.10.101","article-title":"Latency-reversing agents induce differential responses in distinct memory CD4 T cell subsets in individuals on antiretroviral therapy","volume":"29","author":"Pardons","year":"2019","journal-title":"Cell Rep."},{"key":"B119","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/leu.2014.215","article-title":"IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia","volume":"29","author":"Pegram","year":"2015","journal-title":"Leukemia"},{"key":"B120","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1084\/jem.20121932","article-title":"Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production","volume":"210","author":"Perreau","year":"2013","journal-title":"J. Exp. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.chom.2017.03.008","article-title":"Defective HIV-1 proviruses are expressed and can be recognized by cytotoxic T lymphocytes, which shape the proviral landscape","volume":"21","author":"Pollack","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B122","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nbt.4195","article-title":"Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo","volume":"36","author":"Rafiq","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev-med-051914-021702","article-title":"CAR-T Cell Therapy for Lymphoma","volume":"67","author":"Ramos","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/COH.0000000000000279","article-title":"Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?","volume":"11","author":"Rasmussen","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/S2352-3018(14)70014-1","article-title":"Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1\/2, single group, clinical trial","volume":"1","author":"Rasmussen","year":"2014","journal-title":"Lancet HIV"},{"key":"B126","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.celrep.2017.11.075","article-title":"HIV-specific CD8(+) T cells exhibit reduced and differentially regulated cytolytic activity in lymphoid tissue","volume":"21","author":"Reuter","year":"2017","journal-title":"Cell Rep."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1182\/blood-2009-08-237370","article-title":"HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing","volume":"115","author":"Richard","year":"2010","journal-title":"Blood"},{"key":"B128","doi-asserted-by":"publisher","first-page":"e53492","DOI":"10.1371\/journal.pone.0053492","article-title":"Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem\/progenitor cells in humanized BLT mice","volume":"7","author":"Ringpis","year":"2012","journal-title":"PLoS ONE"},{"key":"B129","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1172\/JCI87366","article-title":"Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies","volume":"126","author":"Ruella","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B130","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41598-017-00462-8","article-title":"CRISPR\/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells","volume":"7","author":"Rupp","year":"2017","journal-title":"Sci. Rep."},{"key":"B131","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1038\/ncomms7375","article-title":"Generation of cellular immune memory and B-cell immunity is impaired by natural killer cells","volume":"6","author":"Rydyznski","year":"2015","journal-title":"Nat. Commun."},{"key":"B132","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1158\/2159-8290.CD-17-1319","article-title":"Clinical and Biologic Correlates of Neurotoxicity Associated with CAR T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia (B-ALL)","volume":"8","author":"Santomasso","year":"2018","journal-title":"Cancer Discov."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1172\/JCI46110","article-title":"CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients","volume":"121","author":"Savoldo","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B134","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nature18929","article-title":"HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption","volume":"535","author":"Scheid","year":"2016","journal-title":"Nature"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"B136","doi-asserted-by":"publisher","first-page":"132r","DOI":"10.1126\/scitranslmed.3003761","article-title":"Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells","volume":"4","author":"Scholler","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"e77780","DOI":"10.1371\/journal.pone.0077780","article-title":"PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads","volume":"8","author":"Seung","year":"2013","journal-title":"PLoS ONE"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1182\/blood-2009-04-215855","article-title":"A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model","volume":"115","author":"Shimizu","year":"2010","journal-title":"Blood"},{"key":"B139","doi-asserted-by":"publisher","first-page":"e1005142","DOI":"10.1371\/journal.ppat.1005142","article-title":"The depsipeptide romidepsin reverses HIV-1 latency in vivo","volume":"11","author":"Sogaard","year":"2015","journal-title":"PLoS Pathog."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41590-018-0235-7","article-title":"Recent progress in broadly neutralizing antibodies to HIV","volume":"19","author":"Sok","year":"2018","journal-title":"Nature Immunol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1038\/leu.2017.57","article-title":"Fully human CD19-specific chimeric antigen receptors for T-cell therapy","volume":"31","author":"Sommermeyer","year":"2017","journal-title":"Leukemia"},{"key":"B142","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/cid\/cit813","article-title":"A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy","volume":"58","author":"Spivak","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1097\/00002030-200207260-00004","article-title":"Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial) (vol 16, pg 1479, 2002)","volume":"16","author":"Stellbrink","year":"2002","journal-title":"Aids"},{"key":"B144","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2018.00827","article-title":"The NKG2D\/NKG2DL axis in the crosstalk between lymphoid and myeloid cells in health and disease","volume":"9","author":"Stojanovic","year":"2018","journal-title":"Front. Immunol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.ajpath.2011.06.039","article-title":"Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals","volume":"179","author":"Thompson","year":"2011","journal-title":"Am. J. Pathol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1186\/s12879-017-2683-3","article-title":"Landscape review of current HIV 'kick and kill' cure research - some kicking, not enough killing","volume":"17","author":"Thorlund","year":"2017","journal-title":"BMC Infectious Diseases"},{"key":"B147","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4049\/jimmunol.155.2.1000","article-title":"Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes","volume":"155","author":"Tran","year":"1995","journal-title":"J. Immunol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/nm1106-1329b","article-title":"Upregulation of PD-1 expression on HIV-specific CD8(+) T cells leads to reversible immune dysfunction (vol 12, 1198, 2006)","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat. Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1128\/JVI.02166-16","article-title":"Toll-like receptor 7 agonist GS-9620 induces HIV expression and HIV-specific immunity in cells from HIV-infected individuals on suppressive antiretroviral therapy","volume":"91","author":"Tsai","year":"2017","journal-title":"J. Virol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"e1002636","DOI":"10.1371\/journal.ppat.1002636","article-title":"Treatment with IL-7 prevents the decline of circulating CD4+ T cells during the acute phase of SIV infection in rhesus macaques","volume":"8","author":"Vassena","year":"2012","journal-title":"PLoS Pathog"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/cid\/cix201","article-title":"Short-course toll-like receptor 9 agonist treatment impacts innate immunity and plasma viremia in individuals with human immunodeficiency virus infection","volume":"64","author":"Vibholm","year":"2017","journal-title":"Clin. Infect. Diseases"},{"key":"B152","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nri3478","article-title":"Unravelling the mechanisms of durable control of HIV-1","volume":"13","author":"Walker","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"key":"B154","first-page":"467","article-title":"Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection","volume":"96","author":"Walker","year":"2000","journal-title":"Blood"},{"key":"B155","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ebiom.2016.04.019","article-title":"The effect of latency reversal agents on primary CD8 + T cells: implications for shock and kill strategies for human immunodeficiency virus eradication","volume":"8","author":"Walker-Sperling","year":"2016","journal-title":"EBio.Med."},{"key":"B156","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","article-title":"Microglial cells: the main HIV-1 reservoir in the brain","volume":"9","author":"Wallet","year":"2019","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMoa1802264","article-title":"Effect of anti-CD4 antibody UB-421 on HIV-1 rebound after treatment interruption","volume":"380","author":"Wang","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B158","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1172\/JCI200522574","article-title":"IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART","volume":"115","author":"Wang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"B159","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/mt.2016.24","article-title":"CRISPR-Cas9 can inhibit HIV-1 replication but NHEJ repair facilitates virus escape","volume":"24","author":"Wang","year":"","journal-title":"Mol. Ther."},{"key":"B160","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.virusres.2017.07.020","article-title":"CRISPR-Cas based antiviral strategies against HIV-1","volume":"244","author":"Wang","year":"2018","journal-title":"Virus Res."},{"key":"B161","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.celrep.2016.03.042","article-title":"CRISPR\/Cas9-derived mutations both inhibit HIV-1 replication and accelerate viral escape","volume":"15","author":"Wang","year":"","journal-title":"Cell. Rep."},{"key":"B162","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1128\/JVI.01135-18","article-title":"HIV-1 employs multiple mechanisms to resist Cas9\/single guide RNA targeting the viral primer binding site","volume":"92","author":"Wang","year":"2018","journal-title":"J. Virol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1080\/09540121.2017.1394434","article-title":"Mindfulness instruction for HIV-infected youth: a randomized controlled trial","volume":"30","author":"Webb","year":"2018","journal-title":"AIDS Care"},{"key":"B164","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/1570162X12666140526114526","article-title":"Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders","volume":"12","author":"Williams","year":"2014","journal-title":"Curr. HIV Res."},{"key":"B165","doi-asserted-by":"publisher","first-page":"42008","DOI":"10.1074\/jbc.M402124200","article-title":"Prostratin antagonizes HIV latency by activating NF-kappaB","volume":"279","author":"Williams","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B166","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/B978-0-12-385987-7.00005-1","article-title":"HIV immune evasion disruption of antigen presentation by the HIV Nef protein","volume":"80","author":"Wonderlich","year":"2011","journal-title":"Adv. Virus Res."},{"key":"B167","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1182\/blood-2014-01-552174","article-title":"Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15","volume":"123","author":"Xu","year":"2014","journal-title":"Blood"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ymthe.2017.03.012","article-title":"In vivo excision of HIV-1 provirus by saCas9 and multiplex single-guide RNAs in animal models","volume":"25","author":"Yin","year":"2017","journal-title":"Mol. Ther."},{"key":"B169","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1182\/blood-2013-01-482224","article-title":"Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model","volume":"122","author":"Younan","year":"2013","journal-title":"Blood"},{"key":"B170","author":"Zachary","year":"2018","journal-title":"A Phase 1 Study of ALT-803 (IL-15 Superagonist) to Clear Latent HIV Reservoirs."},{"key":"B171","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1016\/j.celrep.2018.11.104","article-title":"Hematopoietic stem and progenitor cells are a distinct HIV reservoir that contributes to persistent viremia in suppressed patients","volume":"25","author":"Zaikos","year":"2018","journal-title":"Cell Rep."},{"key":"B172","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.4049\/jimmunol.179.7.4910","article-title":"4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy","volume":"179","author":"Zhang","year":"2007","journal-title":"J. Immunol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.4049\/jimmunol.0900447","article-title":"A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity","volume":"183","author":"Zhao","year":"2009","journal-title":"J. Immunol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2217\/imt-2016-0121","article-title":"Chimeric antigen receptor engineered stem cells: a novel HIV therapy","volume":"9","author":"Zhen","year":"","journal-title":"Immunotherapy"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/mt.2015.102","article-title":"HIV-specific immunity derived from chimeric antigen receptor-engineered stem cells","volume":"23","author":"Zhen","year":"2015","journal-title":"Mol. Ther."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v6010001","article-title":"Stem-cell-based gene therapy for HIV infection","volume":"6","author":"Zhen","year":"2013","journal-title":"Viruses"},{"key":"B177","doi-asserted-by":"publisher","first-page":"e1006891","DOI":"10.1371\/journal.ppat.1006891","article-title":"Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV\/AIDS","volume":"14","author":"Zhen","year":"","journal-title":"PLoS Pathog"},{"key":"B178","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s13238-019-0643-y","article-title":"Chimeric antigen receptor T (CAR-T) cells expanded with IL-7\/IL-15 mediate superior antitumor effects","volume":"10","author":"Zhou","year":"2019","journal-title":"Protein Cell."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00410\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T14:04:43Z","timestamp":1696514683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00410\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":178,"alternative-id":["10.3389\/fcimb.2020.00410"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2020.00410","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"article-number":"410"}}